Clinical Trials Browser

Phase 1 × Interventional × CD20-positive Hematological Malignancies × Clear all

NCT07110194 2025-08-07

Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies

Phase 1 Not yet recruiting

CD20-positive Hematological Malignancies